Amphastar Pharmaceuticals, Inc. (AMPH) — DEFA14A Filings
All DEFA14A filings from Amphastar Pharmaceuticals, Inc.. Browse 2 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (2)
-
Amphastar Pharmaceuticals Files Definitive Proxy Statement
— Apr 19, 2024 Risk: low
Amphastar Pharmaceuticals, Inc. filed a Definitive Proxy Statement (DEFA14A) on April 19, 2024. This filing is related to the company's annual meeting and the s -
Amphastar Pharmaceuticals Files Definitive Proxy Statement
— Apr 12, 2024 Risk: low
Amphastar Pharmaceuticals, Inc. filed a definitive proxy statement on April 12, 2024, for its annual meeting of stockholders. The filing indicates that Amphasta
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX